A genome-wide association study of cutaneous squamous cell carcinoma among european descendants

Cancer Epidemiology Biomarkers and Prevention

Volumn 25, Issue 4, 2016, Pages 714-720

  Siiskonen, Satu J ^a   Zhang, Mingfeng ^b   Li, Wen Qing ^c,d   Liang, Liming ^e   Kraft, Peter ^e   Nijsten, Tamar ^a   Han, Jiali ^e,f   Qureshi, Abrar A ^b,c,d,g  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

^d BROWN UNIVERSITY   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DEF8 PROTEIN; ERBB2 INTERACTING PROTEIN; EXOC2 PROTEIN; INTERFERON REGULATORY FACTOR 4; PROTEIN; SIALYLTRANSFERASE; ST3 BETA GALACTOSIDE ALPHA 2,3 SIALYLTRANSFERASE 1; UBAC2 PROTEIN; UNCLASSIFIED DRUG; XRCC1 PROTEIN;

ALLELE; ARTICLE; CHROMOSOME 16; CHROMOSOME 20; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME 8; CONTROLLED STUDY; EUROPE; GENE EXPRESSION; GENE REPLICATION; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE MAP; HUMAN; INTRON; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CARCINOMA; SKIN PIGMENTATION; CASE CONTROL STUDY; CAUCASIAN; FEMALE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MALE; RISK FACTOR; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; RISK FACTORS; SKIN NEOPLASMS;

EID: 84962464474     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-1070     Document Type: Article

References (40)

1. Gerstenblith MR, Shi J, Landi MT. Genome-wide association studies of pigmentation and skin cancer: a review and meta-analysis. Pigment Cell Melanoma Res 2010;23:587-606.
2. Zhang M, Song F, Liang L, Nan H, Zhang J, Liu H, et al. Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans. Hum Mol Genet 2013; 22:2948-59.
3. Box NF, Duffy DL, Irving RE, Russell A, Chen W, Griffyths LR, et al. Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol 2001;116:224-9.
4. Bastiaens MT, ter Huurne JA, Kielich C, Gruis NA, Westendorp RG, Vermeer BJ, et al. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet 2001;68:884-94.
5. Han J, Kraft P, Colditz GA, Wong J, Hunter DJ. Melanocortin 1 receptor variants and skin cancer risk. Int J Cancer 2006;119:1976-84.
6. Han J, Kraft P, Nan H, Guo Q, Chen C, Qureshi A, et al. A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet 2008;4:e1000074.
7. Nan H, Kraft P, Hunter DJ, Han J. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians. Int J Cancer 2009;125:909-17.
8. Nelson HH, Kelsey KT, Mott LA, Karagas MR. The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction. Cancer Res 2002;62:152-5.
9. Kang SY, Lee KG, Lee W, Shim JY, Ji SI, Chung KW, et al. Polymorphisms in the DNA repair gene XRCC1 associated with basal cell carcinoma and squamous cell carcinoma of the skin in a Korean population. Cancer Sci 2007;98:716-20.
10. Welsh MM, Applebaum KM, Spencer SK, Perry AE, Karagas MR, Nelson HH. CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer. Cancer Res 2009;69:6158-63.
11. Nan H, Xu M, Kraft P, Qureshi AA, Chen C, Guo Q, et al. Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma. Hum Mol Genet 2011;20:3718-24.
12. Qi L, Cornelis MC, Kraft P, Stanya KJ, Linda Kao WH, Pankow JS, et al. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet 2010;19:2706-15.
13. Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991;338:464-8.
14. Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, et al. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol 2013;28:889-926.
15. Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 2007; 29:19-24.
16. Flohil SC, Koljenovic S, de Haas ER, Overbeek LI, de Vries E, Nijsten T. Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands. Br J Dermatol 2011;165:874-81.
17. Li Y, Willer C, Sanna S, Abecasis G. Genotype imputation. Annu Rev Genomics Hum Genet 2009;10:387-406.
18. HapMap. Available from: http://www.hapmap.org.
19. Marchini J, Donnelly P, Cardon LR. Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat Genet 2005; 37:413-7.
20. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-9.
21. MATAL. Available from: http://www.sph.umich.edu/csg/abecasis/Metal/index.html.
22. Liang L, Morar N, Dixon AL, Lathrop GM, Abecasis GR, Moffatt MF, et al. A cross-platform analysis of 14, 177 expression quantitative trait loci derived from lymphoblastoid cell lines. Genome Res 2013;23:716-26.
23. eQTLs R-teo. Available from: http://eqtl.rc.fas.harvard.edu/mrce/.
24. Han J, Colditz GA, Hunter DJ. Risk factors for skin cancers: a nested case-control study within the Nurses' Health Study. Int J Epidemiol 2006;35: 1514-21.
25. Picco G, Julien S, Brockhausen I, Beatson R, Antonopoulos A, Haslam S, et al. Over-expression of ST3Gal-I promotes mammary tumorigenesis. Glycobiology 2010;20:1241-50.
26. Videira PA, Correia M, Malagolini N, Crespo HJ, Ligeiro D, Calais FM, et al. ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines. BMC Cancer 2009;9:357.
27. Sproviero D, Julien S, Burford B, Taylor-Papadimitriou J, Burchell JM. Cyclooxygenase-2 enzyme induces the expression of the alpha-2, 3-sialyltransferase-3 (ST3Gal-I) in breast cancer. J Biol Chem 2012;287: 44490-7.
28. Drinnan NB, Halliday J, Ramsdale T. Inhibitors of sialyltransferases: potential roles in tumor growth and metastasis. Mini Rev Med Chem 2003;3:501-17.
29. Ferreira SA, Vasconcelos JL, Silva RC, Cavalcanti CL, Bezerra CL, Rego MJ, et al. Expression patterns of alpha2, 3-sialyltransferase I and alpha2, 6-sialyltransferase I in human cutaneous epithelial lesions. Eur J Histochem 2013;57:e7.
30. Russello SV, Shore SK. SRC in human carcinogenesis. Front Biosci 2004; 9:139-44.
31. Hamilton SR. Molecular genetic alterations as potential prognostic indicators in colorectal carcinoma. Cancer 1992;69:1589-91.
32. Banck MS, Kanwar R, Kulkarni AA, Boora GK, Metge F, Kipp BR, et al. The genomic landscape of small intestine neuroendocrine tumors. J Clin Invest 2013;123:2502-8.
33. Vergani E, Vallacchi V, Frigerio S, Deho P, Mondellini P, Perego P, et al. Identification of MET and SRC activation in melanoma cell lines showing primary resistance to PLX4032. Neoplasia 2011;13:1132-42.
34. Kolch W. Erbin: sorting out ErbB2 receptors or giving Ras a break?Sci STKE 2003;2003:pe37.
35. Lebeau S, Masouye I, Berti M, Augsburger E, Saurat JH, Borradori L, et al. Comparative analysis of the expression of ERBIN and Erb-B2 in normal human skin and cutaneous carcinomas. Br J Dermatol 2005; 152:1248-55.
36. Iwakawa R, Okayama H, Kohno T, Sato-Otsubo A, Ogawa S, Yokota J. Contribution of germline mutations to PARK2 gene inactivation in lung adenocarcinoma. Genes Chromosomes Cancer 2012;51:462-72.
37. Zhang M, Chan MH, Tu WJ, He LR, Lee CM, He M. Using the theory of coevolution to predict protein-protein interactions in non-small cell lung cancer. Chin J Cancer 2013;32:91-8.
38. Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, et al. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblas-toma and other human malignancies. Nat Genet 2010;42:77-82.
39. Mulholland PJ, Fiegler H, Mazzanti C, Gorman P, Sasieni P, Adams J, et al. Genomic profiling identifies discrete deletions associated with transloca-tions in glioblastoma multiforme. Cell Cycle 2006;5:783-91.
40. Letessier A, Garrido-Urbani S, Ginestier C, Fournier G, Esterni B, Monville F, et al. Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer. Oncogene 2007;26:298-307.